A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Clinical trial NCT03434041 · COMPLETED
Trial details
- NCT number
- NCT03434041
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2021-04-13
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.